naproxen has been researched along with gabapentin in 18 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (gabapentin) | Trials (gabapentin) | Recent Studies (post-2010) (gabapentin) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 4,481 | 767 | 2,069 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Abbadie, C; Bugianesi, RM; Chakravarty, PK; Dai, G; Duffy, JL; Garcia, ML; Green, M; Haedo, RJ; Herrington, JB; Jochnowitz, N; Kaczorowski, GJ; Li, X; Lyons, KA; McGowan, E; McManus, OB; Mistry, S; Shao, PP; Smith, MM; Sun, SY; Swensen, AM; Varughese, DJ; Warren, VA; Ye, F | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chatterjea, D; Hammond, DL; Hurley, RW; Rose Feng, M; Taylor, CP | 1 |
| Boulet, J; Gottshall, S; Harrison, J; Mark, L; Pearson, M; Walker, K; Whiteside, GT | 1 |
| Cohen, AS; Gantenbein, AR; Goadsby, PJ | 1 |
| Esme, H; Gurses, A; Kavuncu, V; Metin, M; Pekcolaklar, A; Solak, O; Yaman, M | 1 |
| Bellamy, CO; Dhaun, N; Lua, J; Whitworth, C | 1 |
| Azemati, S; Khosravi, MB; Sahmeddini, MA | 1 |
| Anderson, D; Beecher, G; Bridgland, L; Power, C; Zochodne, DW | 1 |
| Barakat, A; Diaz-delCastillo, M; Heegaard, AM; Rice, ASC; Sena, ES; Soliman, N; Vollert, J; Zhang, XY | 1 |
| de Dios, C; Green, C; Harvin, JA; Heads, A; Klugh, JM; Lane, SD; Motley, K; Schmitz, JM; Stotts, A; Suchting, R; Webber, HE; Yoon, JH | 1 |
2 review(s) available for naproxen and gabapentin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systematic review and meta-analysis of studies in which burrowing behaviour was assessed in rodent models of disease-associated persistent pain.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Celecoxib; Disease Models, Animal; Gabapentin; Ibuprofen; Male; Naproxen; Pain; Rats; Rodentia | 2022 |
2 trial(s) available for naproxen and gabapentin
| Article | Year |
|---|---|
Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain.
Topics: Adult; Amines; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Naproxen; Pain Measurement; Pain, Postoperative; Patient Compliance; Prospective Studies; Thoracotomy; Treatment Outcome | 2007 |
Gabapentin versus naproxen in the management of failed back surgery syndrome; a randomized controlled trial.
Topics: Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Failed Back Surgery Syndrome; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Iran; Male; Middle Aged; Naproxen; Pain Measurement; Treatment Outcome | 2014 |
14 other study(ies) available for naproxen and gabapentin
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cells, Cultured; Chronic Pain; Dogs; Humans; Hyperalgesia; Inflammation; Mice; Mice, Knockout; Microsomes, Liver; Neuralgia; Patch-Clamp Techniques; Piperidines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tissue Distribution | 2012 |
Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia.
Topics: Acetates; Amines; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Calcium Channels; Cyclohexanecarboxylic Acids; Drug Synergism; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Male; Naproxen; Pregabalin; Rats; Rats, Sprague-Dawley | 2002 |
Pharmacological characterisation of a rat model of incisional pain.
Topics: Amines; Analgesics; Animals; Behavior, Animal; Celecoxib; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Etoricoxib; Foot; Gabapentin; gamma-Aminobutyric Acid; Hindlimb; Hyperalgesia; Indomethacin; Male; Morphine; Muscle, Skeletal; Naproxen; Nociceptors; Pain Threshold; Pain, Postoperative; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sulfonamides; Sulfones; Time Factors; Weight-Bearing | 2004 |
Abnormal blink reflex studies in a patient with supraorbital neuralgia.
Topics: Adult; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Blinking; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Naproxen; Neuralgia; Orbit; Reflex, Abnormal; Treatment Outcome | 2006 |
Quiz Page October 2011: An under-recognized cause of CKD.
Topics: Acidosis; Amines; Anorexia Nervosa; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Creatinine; Cyclohexanecarboxylic Acids; False Negative Reactions; Female; Fluid Therapy; Gabapentin; gamma-Aminobutyric Acid; Glomerulosclerosis, Focal Segmental; Humans; Hypokalemia; Kidney Cortex; Middle Aged; Naproxen; Nephritis, Interstitial; Potassium; Vacuoles | 2011 |
A neuropathic pain syndrome associated with hantavirus infection.
Topics: Adult; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Hantavirus Pulmonary Syndrome; Humans; Male; Naproxen; Neuralgia; Orthohantavirus; Peripheral Nervous System; Small Fiber Neuropathy; Syndrome | 2017 |
An opioid-minimizing multimodal pain regimen reduces opioid exposure and pain in trauma-injured patients at high risk for opioid misuse: Secondary analysis from the mast trial.
Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Bayes Theorem; Gabapentin; Humans; Morphine Derivatives; Naproxen; Opioid-Related Disorders; Pain Management; Pain, Postoperative | 2023 |